Analyst
JPMorgan
Equibles does not estimate personal net worth.
Celine Pannotti is recorded as Analyst at JPMorgan. Celine Pannotti has spoken on 5 earnings calls across 4 companies, most recently for PERNOD RICARD on October 15, 2026. Those appearances were for PERNOD RICARD, HALEON PLC, Haleon plc (HLN) and Essity Aktiebolag (publ). The companies whose calls Celine Pannotti spoke on are classified in the Consumer Defensive and Healthcare sectors.
“So I think sequentially the market seems to have improved, seen decline, but slightly improving. At the same time, you sounded somehow cautious about affordability.”
“My question on North America, so clearly a pleasing start, 1% growth, pricing was very strong. Is that kind of level to be sustained or was there maybe less promo because of the week cold and flu and what kind of pricing are we expecting for the year?”
“My question on North America, so clearly a pleasing start, 1% growth, pricing was very strong. Is that kind of level to be sustained or was there maybe less promo because of the week cold and flu and what kind of pricing are we expecting for the year?”
“So my first question will be on the outlook. Can you try to help us understand, you know, clearly you said that travel retail will be slightly negative for the full year.”
“So my question is coming back on the consumer goods performance with price mix negative. I think you mentioned that you had to roll back some pricing in order to keep some of your customer.”
JPMorgan
Analyst
Transcript header (unverified)
PERNOD RICARD
Beverages - Wineries & Distilleries · Consumer Defensive
HLN
Drug Manufacturers - Specialty & Generic · Healthcare
HALEON PLC
Drug Manufacturers - Specialty & Generic · Healthcare
Essity Aktiebolag (publ)
Household & Personal Products · Consumer Defensive
Q1 FY27 Sales - Webcast
PERNOD RICARD
Haleon Q1 2026 Trading Statement
HALEON PLC
Q3 FY26 Sales Call 16/04/2026 at 9:00 am CEST
PERNOD RICARD
Report for quarter 4 and full-year 2025
Essity Aktiebolag (publ)
